Feng, Xun
Zheng, Huaping
Wang, Mi
Wang, Yiyi
Zhou, Xingli
Zhang, Xiwen
Li, Jishu
Xiao, Yue
Wei, Mintong
Li, Xiaoguang
Hashimoto, Takashi
Li, Jingyi
Funding for this research was provided by:
the National Natural Science Foundation of China (82304062)
the Natural Science Foundation of Sichuan Province (2024NSFSC1626)
the Postdoctoral Fund of Sichuan University (2023SCU12065)
Innovative Research Group Project of the National Natural Science Foundation of China (2024HXBH182)
Sichuan Provincial Postdoctoral Science Foundation (2024M752267)
the Achievement Transformation Demonstration Project of the Key research and development (R&D) Program of Science & Technology Department of Chengdu (2023-YF09-00003-SN)
the Postdoctoral Research Fund of West China Hospital, Sichuan University (2023HXBH098)
Natural Science Foundation of Sichuan Province (2023NSFSC1551)
Article History
Received: 13 August 2024
Revised: 28 April 2025
Accepted: 5 May 2025
First Online: 15 May 2025
Declarations
:
: All participants in this study were derived from the autoimmune bullous disease cohort of West China Hospital (AIBD-WCH). The AIBD-WCH was established in 2016, which was approved by the biomedical research ethics committee of West China Hospital of Sichuan University (Approval number: 2017–241). Written informed consent was obtained from all participants.
: The authors have no relevant financial or non-financial interests to disclose.